11 Apr 2014 17:33
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT OR ANY COPY OF IT
11 April 2014
CIRCASSIA PHARMACEUTICALS PLC
End of Stabilisation Notice
Pursuant to Article 9(3) of Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC), and MAR 2.3.5 (3) of the Financial Conduct Authority Code of Market Conduct, J.P. Morgan Securities plc (Manuel Esteve: Telephone: +44 (0)20 7742 4000), the Stabilising Manager, hereby gives notice that it undertook stabilisation (within the meaning of the rules of the Financial Conduct Authority) in relation to the offer of the following securities, as set out below:
Issuer: | Circassia Pharmaceuticals plc |
Securities/ISIN: | Ordinary Shares of 0.08 pence each (ISIN: GB00BJVD3B28) |
Description of offer: | Initial Public Offering |
Offer price: | 310 pence per Ordinary Share |
Stabilising Manager: | J.P. Morgan Securities Plc |
Stabilisation period: | 13 March 2014 to 11 April 2014 |
Stabilisation started: | 13 March 2014 |
Stabilisation last occurred: | 11 April 2014 |
For each of the dates during which stabilisation transactions were carried out, the price range was as follows:
Date | Minimum Price Paid (GBp) | Maximum Price Paid (GBp) |
13/03/2014 | 309.00 | 310.00 |
14/03/2014 | 309.00 | 310.00 |
17/03/2014 | 307.00 | 310.00 |
18/03/2014 | 309.00 | 310.00 |
19/03/2014 | 309.00 | 310.00 |
20/03/2014 | 308.00 | 310.00 |
21/03/2014 | 307.00 | 308.50 |
24/03/2014 | 304.00 | 307.25 |
25/03/2014 | 304.50 | 306.00 |
26/03/2014 | 303.00 | 305.25 |
27/03/2014 | 290.25 | 303.00 |
28/03/2014 | 292.75 | 299.00 |
31/03/2014 | 298.00 | 303.00 |
01/04/2014 | 296.00 | 303.00 |
02/04/2014 | 299.50 | 301.00 |
03/04/2014 | 298.50 | 301.00 |
04/04/2014 | 301.00 | 304.00 |
07/04/2014 | 303.00 | 306.00 |
08/04/2014 | 306.00 | 308.00 |
09/04/2014 | 306.50 | 310.00 |
10/04/2014 | 309.00 | 310.00 |
11/04/2014 | 305.00 | 310.00 |
Accordingly, J.P. Morgan Securities plc, as Stabilising Manager, has exercised the Over-allotment Option (as described in the Circassia Pharmaceuticals plc prospectus) in respect of 633,380 Ordinary Shares in Circassia Pharmaceuticals Plc.
Disclaimer
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or other excluded territories. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or other excluded territories.
The securities of the Issuer have not been and will not be registered under the U.S. Securities Act of 1933 (the "Securities Act") and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada or Japan and, subject to certain exceptions, may not be offered or sold within Australia, Canada or Japan or to any national, resident or citizen of Australia, Canada or Japan. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions.